US Patent 7816084 TLE3 as a marker for chemotherapy
Patent 7816084 was granted and assigned to Applied Genomics, Inc. on October, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 23 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+209 characters)
Article
Patent abstract
Methods of using TLE3 as a marker for predicting the likelihood that a patient's cancer will respond to chemotherapy. Methods of using TLE3 as a marker for selecting a chemotherapy for a cancer.
Edits on 5 Oct, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Brian Z. Ring0
Douglas T. Ross0
Robert S. Seitz0
Rodney A. Beck0
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07816084 TLE3 as a marker for chemotherapy US Patent 7816084 TLE3 as a marker for chemotherapy
Infobox
Patent Number
078160840
Patent Number
78160840
Edits on 4 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078160840
Date of Patent
October 19, 2010
0Patent Application Number
122779200
Date Filed
November 25, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07816084 TLE3 as a marker for chemotherapy
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07816084
Date of patent
October 19, 2010
Patent application number
12277920
Date Filed
November 25, 2008
Patent primary examiner
Find more entities like US Patent 7816084 TLE3 as a marker for chemotherapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
